Have a feature idea you'd love to see implemented?
Let us know!
RANI Rani Therapeutics Holdings Inc
Price (delayed)
$2.04
Market cap
$116.87M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.06
Enterprise value
$146.32M
Highlights
The EPS has increased by 25% YoY and by 10% from the previous quarter
The net income has grown by 21% YoY and by 8% from the previous quarter
The company's equity has shrunk by 82% YoY but it rose by 10% QoQ
The debt has increased by 11% year-on-year but it has declined by 4.3% since the previous quarter
The quick ratio has dropped by 82% year-on-year and by 19% since the previous quarter
Key stats
What are the main financial stats of RANI
Market
Valuations
Earnings
Shares outstanding
57.29M
Market cap
$116.87M
Enterprise value
$146.32M
Price to earnings (P/E)
N/A
Price to book (P/B)
34.92
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$22.97M
EBITDA
-$20.38M
Free cash flow
-$39.72M
Per share
Balance sheet
Liquidity
EPS
-$1.06
Free cash flow per share
-$1.38
Book value per share
$0.06
Revenue per share
$0
TBVPS
$1.51
Total assets
$43.54M
Total liabilities
$37.77M
Debt
$33.73M
Equity
$3.12M
Working capital
$12.16M
Debt to equity
10.81
Current ratio
1.6
Quick ratio
1.5
Net debt/EBITDA
-1.45
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-56.7%
Return on equity
-429.7%
Return on invested capital
-36.2%
Return on capital employed
-98.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RANI stock price
How has the Rani Therapeutics Holdings stock price performed over time
Intraday
-0.49%
1 week
-13.19%
1 month
-20.62%
1 year
0.99%
YTD
-38.55%
QTD
-5.56%
Financial performance
How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$51.79M
Net income
-$28.17M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 26% YoY and by 10% from the previous quarter
The net income has grown by 21% YoY and by 8% from the previous quarter
Growth
What is Rani Therapeutics Holdings's growth rate over time
Valuation
What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
34.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 25% YoY and by 10% from the previous quarter
The company's equity has shrunk by 82% YoY but it rose by 10% QoQ
Efficiency
How efficient is Rani Therapeutics Holdings business performance
Rani Therapeutics Holdings's return on equity has decreased by 43% QoQ
The ROA has contracted by 42% YoY and by 4.6% from the previous quarter
RANI's ROIC is down by 15% YoY and by 3.1% from the previous quarter
Dividends
What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RANI.
Financial health
How did Rani Therapeutics Holdings financials performed over time
Rani Therapeutics Holdings's total assets is 15% more than its total liabilities
The quick ratio has dropped by 82% year-on-year and by 19% since the previous quarter
The current ratio has shrunk by 81% YoY and by 17% QoQ
The company's equity has shrunk by 82% YoY but it rose by 10% QoQ
The company's debt to equity fell by 13% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.